 Janine Higgins
Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 18 | 2022 | 505 | 2.190 |
Why?
| | Starch | 5 | 2019 | 22 | 1.870 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 153 | 1.320 |
Why?
| | Energy Metabolism | 21 | 2024 | 942 | 1.210 |
Why?
| | Dietary Fats | 7 | 2019 | 315 | 1.090 |
Why?
| | Weight Gain | 17 | 2022 | 559 | 1.080 |
Why?
| | Weight Loss | 14 | 2021 | 837 | 0.970 |
Why?
| | Diet | 13 | 2024 | 1270 | 0.930 |
Why?
| | Postprandial Period | 5 | 2020 | 114 | 0.640 |
Why?
| | Mastication | 4 | 2024 | 12 | 0.610 |
Why?
| | Nutritive Value | 1 | 2019 | 38 | 0.610 |
Why?
| | Insulin | 15 | 2020 | 2506 | 0.600 |
Why?
| | Rats, Wistar | 17 | 2024 | 460 | 0.590 |
Why?
| | Insulin Resistance | 11 | 2023 | 1255 | 0.560 |
Why?
| | Obesity | 19 | 2023 | 3087 | 0.530 |
Why?
| | Eating | 10 | 2025 | 389 | 0.520 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2025 | 2590 | 0.510 |
Why?
| | Blood Glucose | 11 | 2023 | 2325 | 0.500 |
Why?
| | Sleep | 9 | 2023 | 905 | 0.500 |
Why?
| | Circadian Rhythm | 9 | 2023 | 516 | 0.490 |
Why?
| | Dietary Proteins | 4 | 2019 | 136 | 0.470 |
Why?
| | Sleep Deprivation | 7 | 2021 | 206 | 0.470 |
Why?
| | Risk Reduction Behavior | 3 | 2020 | 228 | 0.410 |
Why?
| | Feeding Behavior | 4 | 2025 | 684 | 0.410 |
Why?
| | Lipogenesis | 2 | 2019 | 62 | 0.390 |
Why?
| | Triglycerides | 6 | 2019 | 517 | 0.390 |
Why?
| | Motor Activity | 2 | 2019 | 722 | 0.380 |
Why?
| | Apolipoproteins B | 4 | 1999 | 45 | 0.380 |
Why?
| | Physical Conditioning, Animal | 3 | 2019 | 248 | 0.370 |
Why?
| | Diet Records | 3 | 2022 | 85 | 0.360 |
Why?
| | Adipose Tissue | 7 | 2015 | 657 | 0.360 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 78 | 0.360 |
Why?
| | Body Composition | 5 | 2024 | 715 | 0.310 |
Why?
| | Rats | 21 | 2024 | 5626 | 0.310 |
Why?
| | Ovariectomy | 4 | 2024 | 162 | 0.310 |
Why?
| | Wearable Electronic Devices | 2 | 2022 | 62 | 0.310 |
Why?
| | Vitamin D | 1 | 2013 | 402 | 0.300 |
Why?
| | Health Behavior | 2 | 2020 | 795 | 0.300 |
Why?
| | Glucose | 7 | 2023 | 1044 | 0.300 |
Why?
| | Video Recording | 3 | 2019 | 210 | 0.300 |
Why?
| | Diet, Fat-Restricted | 5 | 2023 | 79 | 0.290 |
Why?
| | Liver | 7 | 2024 | 1848 | 0.280 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 360 | 0.280 |
Why?
| | Melatonin | 4 | 2023 | 163 | 0.270 |
Why?
| | Adipocytes | 4 | 2015 | 221 | 0.260 |
Why?
| | Work Schedule Tolerance | 2 | 2020 | 52 | 0.260 |
Why?
| | Lipoproteins, VLDL | 3 | 1999 | 20 | 0.250 |
Why?
| | Amylose | 3 | 2003 | 4 | 0.240 |
Why?
| | Prevotella | 1 | 2025 | 26 | 0.230 |
Why?
| | Fish Oils | 4 | 2000 | 26 | 0.230 |
Why?
| | Male | 40 | 2025 | 71757 | 0.230 |
Why?
| | Food | 1 | 2006 | 152 | 0.230 |
Why?
| | Family | 1 | 2009 | 692 | 0.220 |
Why?
| | Monitoring, Physiologic | 3 | 2025 | 291 | 0.220 |
Why?
| | Hypoglycemic Agents | 2 | 2011 | 1393 | 0.220 |
Why?
| | Colorectal Neoplasms | 1 | 2013 | 850 | 0.220 |
Why?
| | Lithium | 1 | 2004 | 41 | 0.220 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 753 | 0.210 |
Why?
| | Humans | 46 | 2025 | 144228 | 0.210 |
Why?
| | Caloric Restriction | 3 | 2019 | 131 | 0.210 |
Why?
| | Metabolism | 1 | 2004 | 44 | 0.210 |
Why?
| | Dietary Fiber | 1 | 2004 | 58 | 0.200 |
Why?
| | Health | 1 | 2004 | 82 | 0.200 |
Why?
| | Intra-Abdominal Fat | 2 | 2019 | 101 | 0.200 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.200 |
Why?
| | Cross-Over Studies | 3 | 2019 | 596 | 0.200 |
Why?
| | Female | 29 | 2025 | 77795 | 0.200 |
Why?
| | Biosensing Techniques | 1 | 2025 | 145 | 0.200 |
Why?
| | Dietary Fats, Unsaturated | 3 | 2000 | 24 | 0.190 |
Why?
| | Wakefulness | 3 | 2020 | 169 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2346 | 0.190 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 250 | 0.190 |
Why?
| | Body Weight | 5 | 2024 | 993 | 0.180 |
Why?
| | Animals | 31 | 2024 | 38231 | 0.180 |
Why?
| | Cholesterol | 3 | 2019 | 398 | 0.180 |
Why?
| | Chylomicrons | 3 | 1999 | 19 | 0.180 |
Why?
| | Actigraphy | 1 | 2022 | 142 | 0.180 |
Why?
| | Time Factors | 9 | 2022 | 7081 | 0.170 |
Why?
| | Overweight | 2 | 2018 | 608 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2025 | 320 | 0.170 |
Why?
| | Adolescent | 14 | 2025 | 22282 | 0.170 |
Why?
| | Bone Remodeling | 1 | 2021 | 77 | 0.170 |
Why?
| | Hot Temperature | 2 | 2003 | 406 | 0.170 |
Why?
| | Estradiol | 1 | 2024 | 539 | 0.160 |
Why?
| | Ovary | 2 | 2024 | 227 | 0.160 |
Why?
| | Endoplasmic Reticulum, Rough | 2 | 1999 | 4 | 0.160 |
Why?
| | Intestines | 2 | 2014 | 358 | 0.160 |
Why?
| | Obesity, Morbid | 1 | 2024 | 278 | 0.160 |
Why?
| | Patient Compliance | 1 | 2004 | 614 | 0.160 |
Why?
| | Adult | 18 | 2025 | 40230 | 0.160 |
Why?
| | Enterocytes | 1 | 1999 | 16 | 0.150 |
Why?
| | Oxidation-Reduction | 4 | 2019 | 1098 | 0.150 |
Why?
| | Muscle, Skeletal | 6 | 2021 | 1809 | 0.150 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 215 | 0.150 |
Why?
| | Body Fat Distribution | 1 | 2019 | 46 | 0.150 |
Why?
| | Physical Exertion | 2 | 2011 | 211 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 17 | 0.150 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 324 | 0.150 |
Why?
| | Double-Blind Method | 2 | 2019 | 2023 | 0.150 |
Why?
| | Thermogenesis | 1 | 2019 | 45 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.140 |
Why?
| | Subcutaneous Fat | 1 | 2019 | 79 | 0.140 |
Why?
| | Hyperglycemia | 1 | 2022 | 370 | 0.140 |
Why?
| | Adaptation, Physiological | 4 | 2017 | 572 | 0.140 |
Why?
| | Oxygen Consumption | 2 | 2019 | 725 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 121 | 0.140 |
Why?
| | Body Mass Index | 3 | 2024 | 2446 | 0.140 |
Why?
| | Kinetics | 5 | 2006 | 1625 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 92 | 0.140 |
Why?
| | Cold Temperature | 1 | 2019 | 203 | 0.130 |
Why?
| | HIV Infections | 2 | 2025 | 3061 | 0.130 |
Why?
| | Cortical Bone | 1 | 2017 | 19 | 0.130 |
Why?
| | Ibuprofen | 1 | 2017 | 83 | 0.120 |
Why?
| | Menopause | 1 | 2019 | 316 | 0.120 |
Why?
| | Metagenome | 2 | 2019 | 148 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2024 | 630 | 0.120 |
Why?
| | Biomarkers | 4 | 2021 | 4258 | 0.120 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2101 | 0.120 |
Why?
| | Bone Density | 1 | 2019 | 501 | 0.120 |
Why?
| | Osteogenesis | 1 | 2017 | 206 | 0.110 |
Why?
| | Breakfast | 1 | 2015 | 20 | 0.110 |
Why?
| | Glycogen | 3 | 2008 | 55 | 0.110 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2011 | 3847 | 0.110 |
Why?
| | Sleep Stages | 1 | 2014 | 76 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2020 | 517 | 0.110 |
Why?
| | Models, Statistical | 1 | 2019 | 680 | 0.110 |
Why?
| | Deglutition | 1 | 2014 | 72 | 0.110 |
Why?
| | Child | 8 | 2022 | 22493 | 0.100 |
Why?
| | Satiation | 1 | 2014 | 28 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 342 | 0.100 |
Why?
| | Fermentation | 1 | 2014 | 32 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 24 | 0.100 |
Why?
| | Meals | 3 | 2022 | 132 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 56 | 0.100 |
Why?
| | Plant Oils | 4 | 2000 | 31 | 0.090 |
Why?
| | HIV-1 | 1 | 2019 | 906 | 0.090 |
Why?
| | Adiposity | 4 | 2023 | 537 | 0.090 |
Why?
| | Polysomnography | 2 | 2025 | 240 | 0.090 |
Why?
| | Recurrence | 4 | 2019 | 1123 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 158 | 0.090 |
Why?
| | Fatty Acids, Volatile | 2 | 2019 | 60 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 32 | 0.090 |
Why?
| | Calorimetry, Indirect | 3 | 2024 | 86 | 0.090 |
Why?
| | Random Allocation | 3 | 2023 | 364 | 0.080 |
Why?
| | Young Adult | 7 | 2025 | 13949 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 187 | 0.080 |
Why?
| | Tritium | 2 | 2006 | 68 | 0.080 |
Why?
| | Golgi Apparatus | 2 | 1998 | 102 | 0.080 |
Why?
| | Exercise | 2 | 2018 | 2198 | 0.080 |
Why?
| | Feces | 2 | 2025 | 509 | 0.070 |
Why?
| | Colorado | 1 | 2019 | 4591 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2502 | 0.070 |
Why?
| | Aging | 1 | 1999 | 1972 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 867 | 0.070 |
Why?
| | Photography | 1 | 2009 | 114 | 0.070 |
Why?
| | Lipid Metabolism | 4 | 2011 | 524 | 0.070 |
Why?
| | Mice | 4 | 2022 | 18471 | 0.070 |
Why?
| | Lipids | 4 | 2010 | 701 | 0.060 |
Why?
| | Phospholipids | 2 | 1988 | 211 | 0.060 |
Why?
| | Digestion | 1 | 2006 | 11 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3402 | 0.060 |
Why?
| | Amylopectin | 2 | 1996 | 4 | 0.060 |
Why?
| | Disease Models, Animal | 7 | 2019 | 4578 | 0.060 |
Why?
| | Absorptiometry, Photon | 2 | 2024 | 277 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2014 | 1309 | 0.060 |
Why?
| | Microbiota | 1 | 2014 | 782 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.050 |
Why?
| | Citrates | 1 | 2004 | 42 | 0.050 |
Why?
| | Satiety Response | 1 | 2004 | 11 | 0.050 |
Why?
| | Homosexuality, Male | 1 | 2025 | 215 | 0.050 |
Why?
| | Lipoproteins, LDL | 2 | 2001 | 114 | 0.050 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.050 |
Why?
| | Basal Metabolism | 1 | 2024 | 63 | 0.050 |
Why?
| | Mental Processes | 1 | 2024 | 38 | 0.050 |
Why?
| | Fatty Acids | 3 | 2021 | 450 | 0.050 |
Why?
| | Radioimmunoassay | 1 | 2003 | 167 | 0.050 |
Why?
| | Sunflower Oil | 2 | 1999 | 7 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 188 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 61 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 2032 | 0.040 |
Why?
| | Tetrahydrofolates | 1 | 2001 | 15 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 38 | 0.040 |
Why?
| | Cohort Studies | 3 | 2020 | 5876 | 0.040 |
Why?
| | Rabbits | 2 | 1999 | 657 | 0.040 |
Why?
| | Transcription Factors | 2 | 2019 | 1739 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 321 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1638 | 0.040 |
Why?
| | Collagen Type I | 1 | 2021 | 143 | 0.040 |
Why?
| | Postmenopause | 1 | 2022 | 391 | 0.040 |
Why?
| | Apolipoprotein B-48 | 1 | 1999 | 1 | 0.040 |
Why?
| | Cholesterol Esters | 1 | 1999 | 7 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 1999 | 48 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
| | Phenanthrolines | 1 | 1999 | 7 | 0.040 |
Why?
| | Leptin | 2 | 2014 | 244 | 0.040 |
Why?
| | Leupeptins | 1 | 1999 | 12 | 0.040 |
Why?
| | Apolipoprotein B-100 | 1 | 1999 | 13 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 578 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 97 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 1999 | 200 | 0.040 |
Why?
| | Tissue Distribution | 1 | 1999 | 328 | 0.040 |
Why?
| | Oleic Acid | 1 | 1999 | 42 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 134 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 58 | 0.040 |
Why?
| | Cricetinae | 1 | 1999 | 300 | 0.040 |
Why?
| | Receptors, LDL | 1 | 1998 | 53 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2024 | 2097 | 0.040 |
Why?
| | Prevalence | 1 | 2025 | 2820 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 1999 | 103 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 273 | 0.030 |
Why?
| | Homeostasis | 2 | 2015 | 639 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 162 | 0.030 |
Why?
| | Fatty Acids, Omega-3 | 1 | 1999 | 142 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.030 |
Why?
| | Fasting | 1 | 2020 | 282 | 0.030 |
Why?
| | Middle Aged | 5 | 2025 | 35731 | 0.030 |
Why?
| | Drug Combinations | 1 | 2019 | 378 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 394 | 0.030 |
Why?
| | Glucose Tolerance Test | 2 | 1996 | 376 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1049 | 0.030 |
Why?
| | Metagenomics | 1 | 2019 | 180 | 0.030 |
Why?
| | Dysbiosis | 1 | 2019 | 186 | 0.030 |
Why?
| | Regression Analysis | 1 | 1999 | 1003 | 0.030 |
Why?
| | Running | 1 | 2019 | 232 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 772 | 0.030 |
Why?
| | Life Style | 1 | 2019 | 485 | 0.030 |
Why?
| | Absorption | 1 | 1996 | 60 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1266 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 54 | 0.030 |
Why?
| | Physical Fitness | 1 | 2017 | 208 | 0.030 |
Why?
| | Metformin | 1 | 2019 | 331 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2019 | 435 | 0.030 |
Why?
| | Hyperinsulinism | 1 | 1996 | 114 | 0.030 |
Why?
| | Peptide YY | 1 | 2014 | 24 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 427 | 0.030 |
Why?
| | Ghrelin | 1 | 2014 | 38 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 16805 | 0.030 |
Why?
| | Microsomes | 2 | 1998 | 33 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2019 | 469 | 0.030 |
Why?
| | Resistance Training | 1 | 2017 | 179 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 334 | 0.030 |
Why?
| | Computational Biology | 1 | 2019 | 685 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1682 | 0.030 |
Why?
| | Gene Expression | 1 | 1998 | 1514 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2081 | 0.020 |
Why?
| | Risk Factors | 2 | 2020 | 10641 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5327 | 0.020 |
Why?
| | Calorimetry | 1 | 2013 | 72 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2018 | 786 | 0.020 |
Why?
| | Electromyography | 1 | 2014 | 416 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6380 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 312 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1493 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3295 | 0.020 |
Why?
| | Cells, Cultured | 1 | 1999 | 4172 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3618 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2859 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 6031 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7180 | 0.020 |
Why?
| | Palmitic Acids | 2 | 1988 | 10 | 0.020 |
Why?
| | Physical Examination | 1 | 2010 | 235 | 0.020 |
Why?
| | Hormones | 1 | 2009 | 136 | 0.020 |
Why?
| | Immunosorbent Techniques | 1 | 1988 | 18 | 0.020 |
Why?
| | Palmitic Acid | 1 | 1988 | 42 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2008 | 29 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1988 | 77 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5776 | 0.020 |
Why?
| | Hyperplasia | 1 | 2008 | 174 | 0.020 |
Why?
| | Myocardium | 2 | 1996 | 946 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8154 | 0.020 |
Why?
| | Exercise Test | 1 | 2009 | 621 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 61 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 1988 | 266 | 0.010 |
Why?
| | Down-Regulation | 1 | 2008 | 641 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1762 | 0.010 |
Why?
| | Copper | 2 | 2001 | 113 | 0.010 |
Why?
| | United States | 1 | 2020 | 15641 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2630 | 0.010 |
Why?
| | Homocysteine | 1 | 2001 | 151 | 0.010 |
Why?
| | Nutritional Physiological Phenomena | 1 | 1981 | 54 | 0.010 |
Why?
| | Catalysis | 1 | 2001 | 326 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2008 | 2541 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 1029 | 0.010 |
Why?
| | Aged | 2 | 2019 | 25675 | 0.010 |
Why?
| | Endoplasmic Reticulum, Smooth | 1 | 1998 | 4 | 0.010 |
Why?
| | Protamines | 2 | 1969 | 8 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 75 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1836 | 0.010 |
Why?
| | Quality of Life | 1 | 2010 | 3146 | 0.010 |
Why?
| | Cytoplasmic Granules | 1 | 1998 | 74 | 0.010 |
Why?
| | Sodium Chloride | 2 | 1969 | 142 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1969 | 564 | 0.010 |
Why?
| | Organ Specificity | 1 | 1996 | 315 | 0.010 |
Why?
| | Alcoholism | 1 | 1981 | 814 | 0.010 |
Why?
| | Lung | 1 | 1967 | 4159 | 0.010 |
Why?
| | Acyltransferases | 1 | 1972 | 79 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2001 | 2413 | 0.010 |
Why?
| | Chemistry | 1 | 1969 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1969 | 80 | 0.000 |
Why?
| | Sulfates | 1 | 1969 | 49 | 0.000 |
Why?
| | Isoenzymes | 1 | 1967 | 300 | 0.000 |
Why?
| | Heparin | 1 | 1967 | 250 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1967 | 1055 | 0.000 |
Why?
| | Nutritional Requirements | 1 | 1981 | 77 | 0.000 |
Why?
| | Nitrogen | 1 | 1981 | 169 | 0.000 |
Why?
| | Isoflurophate | 1 | 1972 | 3 | 0.000 |
Why?
| | Glycerophosphates | 1 | 1972 | 4 | 0.000 |
Why?
| | Coenzyme A | 1 | 1972 | 7 | 0.000 |
Why?
| | Methods | 1 | 1972 | 67 | 0.000 |
Why?
| | Glycerides | 1 | 1972 | 18 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1972 | 79 | 0.000 |
Why?
| | Carbon Isotopes | 1 | 1972 | 143 | 0.000 |
Why?
| | Microscopy, Electron | 1 | 1972 | 415 | 0.000 |
Why?
|
|
Higgins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|